{"changes":[],"country":"US","description":"Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas","domain":"myosintherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":26.934225,"lng":-80.094209,"location":"JUPITER, Florida","name":"MYOSIN THERAPEUTICS INC","rounds":[{"amountQuarantined":false,"amountUsd":3157209,"currency":"USD","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"myosintherapeutics-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"myosintherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://myosintherapeutics.com"},{"fact":"description","publisher":"myosintherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://myosintherapeutics.com"}],"stage":null,"techStack":["LiteSpeed","jquery 3.3.1"],"totalRaisedUsd":3157209,"updatedAt":"2026-05-07"}